KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Retained Earnings (2016 - 2025)

Rigel Pharmaceuticals (RIGL) has 16 years of Retained Earnings data on record, last reported at $181000.0 in Q4 2025.

  • For Q4 2025, Retained Earnings rose 100.01% year-over-year to $181000.0; the TTM value through Dec 2025 reached $181000.0, up 100.01%, while the annual FY2025 figure was $181000.0, 100.01% up from the prior year.
  • Retained Earnings reached $181000.0 in Q4 2025 per RIGL's latest filing, up from $96000.0 in the prior quarter.
  • Across five years, Retained Earnings topped out at $181000.0 in Q4 2025 and bottomed at -$1.4 billion in Q2 2024.
  • Average Retained Earnings over 5 years is -$890.0 million, with a median of -$1.3 billion recorded in 2021.
  • Peak YoY movement for Retained Earnings: crashed 33097050.0% in 2021, then soared 100.01% in 2025.
  • A 5-year view of Retained Earnings shows it stood at -$1.3 billion in 2021, then decreased by 4.42% to -$1.4 billion in 2022, then fell by 1.81% to -$1.4 billion in 2023, then increased by 1.24% to -$1.4 billion in 2024, then skyrocketed by 100.01% to $181000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Retained Earnings were $181000.0 in Q4 2025, $96000.0 in Q3 2025, and -$1.3 billion in Q2 2025.